• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于设计的无量纲质量的尺度无关模型作为药物开发加速器

Scale-Agnostic Models Based on Dimensionless Quality by Design as Pharmaceutical Development Accelerator.

作者信息

Romero-Obon Miquel, Sancho-Ochoa Virginia, Rouaz-El-Hajoui Khadija, Pérez-Lozano Pilar, Suñé-Pou Marc, Suñé-Negre Josep María, García-Montoya Encarna

机构信息

Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.

Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group, Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran via de l'Hospitalet, 199-203, 08090 Barcelona, Spain.

出版信息

Pharmaceuticals (Basel). 2025 Jul 11;18(7):1033. doi: 10.3390/ph18071033.

DOI:10.3390/ph18071033
PMID:40732320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12301016/
Abstract

This comprehensive review of the synergistic use of Quality by Design (QbD) and the Pi-Buckingham theorem explores an innovative approach to enhancing product development and process optimization within the pharmaceutical industry. QbD is a systematic, proactive methodology that integrates quality considerations throughout the product lifecycle to ensure that pharmaceutical products meet regulatory standards for safety and efficacy from the outset of development. The Pi-Buckingham theorem serves as a foundational principle in dimensional analysis, facilitating the simplification of complex models by transforming physical variables into dimensionless parameters. This synergy enables researchers to better understand and control the factors affecting critical quality attributes (CQAs), thereby improving manufacturing outcomes and minimizing variability.

摘要

对质量源于设计(QbD)与π-白金汉定理协同使用的这一全面综述,探索了一种创新方法,以加强制药行业内的产品开发和工艺优化。质量源于设计是一种系统的、主动的方法,它在产品整个生命周期内整合质量考量,以确保药品从开发之初就符合安全和有效性的监管标准。π-白金汉定理是量纲分析中的一个基本原理,通过将物理变量转化为无量纲参数,有助于简化复杂模型。这种协同作用使研究人员能够更好地理解和控制影响关键质量属性(CQA)的因素,从而改善生产结果并将变异性降至最低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f2/12301016/0da2cf50156f/pharmaceuticals-18-01033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f2/12301016/3ff231267741/pharmaceuticals-18-01033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f2/12301016/740d61574886/pharmaceuticals-18-01033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f2/12301016/794376cbc5a3/pharmaceuticals-18-01033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f2/12301016/0da2cf50156f/pharmaceuticals-18-01033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f2/12301016/3ff231267741/pharmaceuticals-18-01033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f2/12301016/740d61574886/pharmaceuticals-18-01033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f2/12301016/794376cbc5a3/pharmaceuticals-18-01033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f2/12301016/0da2cf50156f/pharmaceuticals-18-01033-g004.jpg

相似文献

1
Scale-Agnostic Models Based on Dimensionless Quality by Design as Pharmaceutical Development Accelerator.基于设计的无量纲质量的尺度无关模型作为药物开发加速器
Pharmaceuticals (Basel). 2025 Jul 11;18(7):1033. doi: 10.3390/ph18071033.
2
A roadmap for model-based bioprocess development.基于模型的生物工艺开发路线图。
Biotechnol Adv. 2024 Jul-Aug;73:108378. doi: 10.1016/j.biotechadv.2024.108378. Epub 2024 May 15.
3
Rethinking Pharmaceutical Industry with Quality by Design: Application in Research, Development, Manufacturing, and Quality Assurance.用质量源于设计理念重塑制药行业:在研发、生产及质量保证中的应用
AAPS J. 2025 May 20;27(4):96. doi: 10.1208/s12248-025-01079-w.
4
An Up-to-Date Screening on the Tool of Quality by Design in Pharmaceutical Manufacturing.制药生产中质量源于设计工具的最新筛选
Comb Chem High Throughput Screen. 2025 Jul 21. doi: 10.2174/0113862073388521250708101658.
5
Quality by Design Considerations for Drop-on-Demand Point-of-Care Pharmaceutical Manufacturing of Precision Medicine.按需滴定点医疗制药的质量源于设计考虑因素。
Mol Pharm. 2024 Jul 1;21(7):3268-3280. doi: 10.1021/acs.molpharmaceut.4c00032. Epub 2024 Apr 25.
6
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
7
Accreditation through the eyes of nurse managers: an infinite staircase or a phenomenon that evaporates like water.护士长眼中的认证:是无尽的阶梯还是如流水般消逝的现象。
J Health Organ Manag. 2025 Jun 30. doi: 10.1108/JHOM-01-2025-0029.
8
Wood Waste Valorization and Classification Approaches: A systematic review.木材废料的增值与分类方法:一项系统综述
Open Res Eur. 2025 May 6;5:5. doi: 10.12688/openreseurope.18862.1. eCollection 2025.
9
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review.髋、膝或髋膝骨关节炎患者的运动干预和患者信念:一项混合方法综述
Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD010842. doi: 10.1002/14651858.CD010842.pub2.
10
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.

本文引用的文献

1
Quality by Design for Preclinical In Vitro Assay Development.临床前体外分析方法开发的质量源于设计
Pharm Stat. 2025 Jan-Feb;24(1):e2430. doi: 10.1002/pst.2430. Epub 2024 Sep 24.
2
Drilling into "Quality by Design" Approach for Analytical Methods.深入探究分析方法的“质量源于设计”理念
Crit Rev Anal Chem. 2024;54(8):3478-3519. doi: 10.1080/10408347.2023.2253321. Epub 2023 Sep 4.
3
Implementation of Quality by Design in the Formulation and Development of Nanocarrier-Based Drug Delivery Systems.基于纳米载体的药物递送系统的处方设计与开发中质量源于设计的实施
Crit Rev Ther Drug Carrier Syst. 2023;40(3):1-46. doi: 10.1615/CritRevTherDrugCarrierSyst.2022042927.
4
Quality by Design Approach in Liposomal Formulations: Robust Product Development.质量源于设计在脂质体制剂中的应用:稳健的产品开发。
Molecules. 2022 Dec 20;28(1):10. doi: 10.3390/molecules28010010.
5
Data-driven discovery of dimensionless numbers and governing laws from scarce measurements.从稀缺测量中发现无量纲数和控制律的数据驱动方法。
Nat Commun. 2022 Dec 8;13(1):7562. doi: 10.1038/s41467-022-35084-w.
6
Quality by Design for enabling RNA platform production processes.通过设计质量使 RNA 平台生产工艺成为可能。
Trends Biotechnol. 2022 Oct;40(10):1213-1228. doi: 10.1016/j.tibtech.2022.03.012. Epub 2022 Apr 29.
7
Application of quality by design in the current drug development.质量源于设计在当前药物研发中的应用。
Asian J Pharm Sci. 2017 Jan;12(1):1-8. doi: 10.1016/j.ajps.2016.07.006. Epub 2016 Aug 4.
8
Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives.药品制造中的质量源于设计:现状、挑战和未来展望的系统评价。
Eur J Pharm Biopharm. 2020 Feb;147:19-37. doi: 10.1016/j.ejpb.2019.12.007. Epub 2019 Dec 17.
9
Multi-dimensional population balance modelling of pharmaceutical formulations for continuous twin-screw wet granulation: Determination of liquid distribution.多维度药物制剂连续双螺杆湿法造粒的颗粒群平衡模型建立:液体分布的测定。
Int J Pharm. 2019 Jul 20;566:352-360. doi: 10.1016/j.ijpharm.2019.06.001. Epub 2019 Jun 3.
10
Quality by Design: Concept to Applications.设计质量:从概念到应用。
Curr Drug Discov Technol. 2019;16(3):240-250. doi: 10.2174/1570163815666180308142016.